130 related articles for article (PubMed ID: 10379631)
1. Neuromuscular blocking characteristics of vecuronium after tubocurarine-induced "fade". An experimental double-blind clinical study.
Puura A; Baer GA; Rorarius MG
Eur J Clin Pharmacol; 1999 May; 55(3):173-6. PubMed ID: 10379631
[TBL] [Abstract][Full Text] [Related]
2. The effect of d-tubocurarine priming on an ED95 dose of vecuronium bromide.
Miguel RV; Barlow IK; Dombrowski DL
J Clin Anesth; 1994; 6(2):106-9. PubMed ID: 7911306
[TBL] [Abstract][Full Text] [Related]
3. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
Gibson FM; Mirakhur RK
Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
[TBL] [Abstract][Full Text] [Related]
5. Duration of action of vecuronium after an intubating dose of rapacuronium, vecuronium, or succinylcholine.
Gan TJ; Madan R; Alexander R; Jhaveri R; El-Moalem H; Weatherwax K; Glass PS
Anesth Analg; 2001 May; 92(5):1199-202. PubMed ID: 11323346
[TBL] [Abstract][Full Text] [Related]
6. Observations of the potency and duration of vecuronium in isoflurane-anesthetized horses.
Martin-Flores M; Pare MD; Adams W; Campoy L; Gleed RD
Vet Anaesth Analg; 2012 Jul; 39(4):385-9. PubMed ID: 22642379
[TBL] [Abstract][Full Text] [Related]
7. Relationships between block-of-twitch and train-of-four fade in the mouse phrenic nerve-diaphragm preparation.
Storella RJ; Slomowitz SA; Rosenberg H
Can J Anaesth; 1991 Apr; 38(3):401-7. PubMed ID: 1674678
[TBL] [Abstract][Full Text] [Related]
8. Tetanic fade following administration of nondepolarizing neuromuscular blocking drugs.
Gibson FM; Mirakhur RK
Anesth Analg; 1989 Jun; 68(6):759-62. PubMed ID: 2567584
[TBL] [Abstract][Full Text] [Related]
9. "Train-of-four" fade during clinical nondepolarizing neuromuscular block.
Gyermek L; Berman N
Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):122-7. PubMed ID: 1533392
[TBL] [Abstract][Full Text] [Related]
10. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
11. Train-of-four fade during onset and recovery of neuromuscular block: a study in non-anaesthetized subjects.
Turner GA; Williams JD; Baker DJ
Br J Anaesth; 1989 Mar; 62(3):279-86. PubMed ID: 2564783
[TBL] [Abstract][Full Text] [Related]
12. Precurarization and priming: a theoretical analysis of safety and timing.
Kopman AF; Khan NA; Neuman GG
Anesth Analg; 2001 Nov; 93(5):1253-6. PubMed ID: 11682407
[TBL] [Abstract][Full Text] [Related]
13. Priming with nondepolarizing relaxants for rapid tracheal intubation: a double-blind evaluation.
Baumgarten RK; Carter CE; Reynolds WJ; Brown JL; DeVera HV
Can J Anaesth; 1988 Jan; 35(1):5-11. PubMed ID: 2894903
[TBL] [Abstract][Full Text] [Related]
14. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey.
Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH
Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358
[TBL] [Abstract][Full Text] [Related]
18. The pharmacodynamics of vecuronium in chronic renal failure patients: the impact of different priming doses.
Tarbeeh GA; Othman MM
Ren Fail; 2012; 34(7):827-33. PubMed ID: 22607043
[TBL] [Abstract][Full Text] [Related]
19. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
Itoh H; Shibata K; Nitta S; Kobayashi T
Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
[TBL] [Abstract][Full Text] [Related]
20. [Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade].
Munakata K; Suzuki T; Watanabe N; Nagai H; Kakishita M; Saeki S; Ogawa S
Masui; 2004 Dec; 53(12):1377-80. PubMed ID: 15682798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
